Introduction
The Notch signaling pathway is involved in cell fate decisions of tissues and organs in several different organisms (reviewed in Callahan and Raafat, 2001) . In mammals there are four members of the Notch gene family, some of which are targets for mutations that contribute to tumor development (reviewed in Allenspach et al., 2002) . Notch4 was originally identified as a common insertion site (CIS) for the mouse mammary tumor virus (MMTV) in infected mouse mammary tumors (Gallahan et al., 1987) . One consequence of MMTV integration into Notch4 is the transcription of a truncated Notch4 RNA species (designated Int3) that represents a gain of function mutation (Robbins et al., 1992; Gallahan and Callahan, 1997) . Transcription of Int3 RNA begins in the 3 0 MMTV long-terminal repeat (LTR) sequence and continues through the adjacent 3 0 portion of the gene. The Int3 RNA species encodes a protein that spans the Lin12/Notch repeats (LNR) through the entire intracellular domain (ICD) of the receptor protein. Expression of the Int3 RNA species in the HC11 mouse mammary epithelial cell line confers on it the capability of anchorage-independent growth in soft agar (Robbins et al., 1992) . Expression of Int3 as a transgene from the whey acid protein (WAP) promoter (Figure 1a) or the MMTV LTR in transgenic mice blocks normal mammary lobular development and the ability of these females to lactate (Jhappan et al., 1992; Smith et al., 1995; Gallahan et al., 1996) . In addition, 100% of the females of each transgenic mouse strain develop mammary tumors.
A survey of human tumor cell lines for the expression of novel Notch4 RNA species revealed a 1.8 kb RNA species in certain breast, colon and lung carcinoma cell lines (Imatani and Callahan, 2000) . This human RNA species (designated h-Int3sh) in normal tissues has been detected only in the testis and encodes a portion of the Notch4 ICD. Its transcription seems to be initiated from a cryptic transcription promoter in intron 26 of human Notch4. Initiation of translation from h-Int3sh RNA begins at a methionine residue that is the sixth aminoacid residue of the first CDC10/Ankryn repeat in the ICD. Thus, this truncated Notch4 protein species is missing the RAM23 region of the Notch4 ICD that is necessary for the binding of the CBF1 repressor/ transcription factor (reviewed in Callahan and Raafat, 2001) .
Several studies suggest that there are at least two genetically separable components to Notch signaling: one that is dependent on CBF1 binding to RAM23 region of the Notch ICD and the other that is CBF1-independent (reviewed in Martinez Arias et al., 2002) . Expression of h-Int3sh in the MCF10A 'normal' human mammary epithelial cell line confers on it the capability of growth in soft agar, a property that is generally associated with tumor induction in vivo (Imatani and Callahan, 2000) . This suggests that the consequences of h-Int3sh signaling are CBF1-independent. Two studies (Dumont et al., 2000; Jeffries and Capobianco, 2000) aimed at defining the minimal region of the Notch1 ICD required for neoplastic transformation of tissue culture cells in vitro were also consistent with the conclusion that it is the CBF1-independent component of Notch signaling that is operative in the induction of soft agar growth. To investigate the biological consequences of RAM23-dependent and -independent pathways on mammary gland development and tumorigenesis in vivo, we have developed strains of WAP-h-Int3sh transgenic mice and compared them to the WAP-Int3 mice.
Results
We have developed transgenic mouse strains that express h-Int3sh under the control of WAP promoter to assess the effects in vivo of elevated h-Int3 expression on mammary gland development and tumorigenesis ( Figure 1a) . To identify the transgenic lines that express WAP-h-Int3sh, total RNA was isolated from mammary glands of 15-days-pregnant transgenic mice and subjected to reverse transcriptase polymerase chain reaction (RT-PCR) analysis. Using this approach, we identified three independent lines (K5, N2 and P1) of mice expressing WAP-h-Int3sh in the mammary gland ( Figure 1b ). To confirm these results, protein extracts from 15-days-pregnant females of these three expressing transgenic lines were subjected to Western blot analysis ( Figure 1c ). Data from transgenic line K5 and N2 are not shown.
Morphological analysis of the mammary glands from females of each of the three strains showed normal mammary gland development. The whole mount of an inguinal mammary fat pad from a 15-days-pregnant WAP-h-Int3sh (Figure 2a ) mouse is similar to that of a normal 15-days-pregnant FVB/N mouse ( Figure 2e ). Moreover, histological examination of H&E-stained mammary sections also showed that the WAP-h-Int3sh ductal and alveolar development was normal (compare Figure 2b and f). The morphology of these glands is grossly different from those of pregnant WAP-Int3 mice (Figure 2c and d) in that there is virtually no lobular development in the mammary glands of the latter mice (Gallahan et al., 1996) . In addition, the WAP-h-Int3sh females can lactate, whereas the WAP-Int3 females cannot.
Mammary tumors develop in 100% of the WAP-Int3 females. In breeding females 50% are tumor-free at 4.5 months, whereas 50% of virgin females are tumor-free at 9.5 months of age (Figure 3) . We have monitored the three founder lines (K5, N2, and P1) of WAP-h-Int3sh females for mammary tumor development for 23 months (Table 1) . Females in each founder line develop mammary tumors; in fact, five WAP-h-Int3sh females developed two to five tumors in the 10 mammary glands. However, as shown for the P1 founder line (Figure 3) , the mean latency is longer (16 months) and the overall frequency (35%) is less than in WAP-Int3 females.
A comparison of the histopathology of WAP-Int3 ( Figure 4a ) and WAP-h-Int3sh mammary tumors shows that WAP-Int3 mammary tumors were adenocarcinomas. Tumor cells had hyperchromatic nuclei and a high nuclear to cytoplasmic ratio. There were a moderate number of mitoses. Tumor lumens were small and irregular. WAP-h-Int3sh mammary tumors were more differentiated than the WAP-Int3 tumors. They were predominantly adenosquamous (metaplastic) carcinomas (Figure 4b ). The glandular portion of these tumors (Gallahan et al., 1996) . Various domains of the Int3 protein are indicated: LNR, LIN12/ Notch repeats; TM, transmembrane domain; RAM23, CBF1-binding region; CDC10/ANKR, CDC10/Ankyrin repeats, NS, nuclear localization signal sequence and the PEST motif. (b) The WAP-h-Int3sh vector. It contains nucleotides 4855-6102 (Li et al., 1998) of the human Notch4/Int3 cDNA. This fragment of Notch4/ Int3 was prepared by PCR using the forward primer 5 0 -GGAAGCTTCACCCCTGATGTCAGCAGTTTGC-3 0 and the reverse primer 5 0 -GGGGGATCCCTACTTG TCATCGTCGTCC TTGTAGTCTTTTTTACCCTCTCCTCCTTGGTTTAT-3 0 . The PCR product was ligated into the PBS/WAP promoter vector (Gallahan et al., 1996) at the HindIII/BamHI sites (shown as H and B, and a unique EcoRI (E) site). Preparation of DNA for microinjection and development of transgenic mice has been described (Gallahan et al., 1996) . ( and mitoses were frequent (Figure 4b ). Scattered throughout the WAP-h-Int3sh tumors were foci of stratified squamous keratinizing epithelium (Figure 4c ).
In vertebrates, Hes1 expression is directly upregulated by a Notch ICD-CBF1 interaction and is considered the primary effecter of CBF1-dependent Notch signaling (reviewed in Callahan and Raafat, 2001; Martinez Arias et al., 2002) . Hes1 encodes a basic helix-loop-helix protein that represses differentiation. As shown in Figure 5a , however, Hes1 expression can be detected in RNA from WAP-h-Int3sh and, as expected, WAPInt3 mammary tumors. Recently, Jeffries et al. (2002) have provided evidence that deletion of the RAM23 domain does not necessarily equate to CBF1-independent Notch signaling. Thus, in our transgenic WAP-hInt3sh model, mammary tumor development could still be a consequence of CBF1-dependent Notch signaling. To test this possibility, we generated a HES1 promoterluciferase reporter vector and introduced it with varying amounts (0.1, 0.3 or 0.5 mg) of EF1-Int3-ICD or EFI-hInt3sh into cultured COS-1 cells by transfection. There was a progressive increase in reporter gene activity as the concentration of Int3 and Int3sh increased from 0.1 to 0.5 mg. Expression of the reporter gene was robust in Cells were lysed 24 h after the transfection and luciferase activities were assayed. Renilla luciferase activities of co-transfected pRL-TK were used to normalize transfection efficiency. All transfections were performed in triplicate and the bar graph shows results from three separate experiments the EF1-Int3-transfected cells, and was 2.7-fold higher than that seen with the matching EFI-h-Int3sh-transfected cells.
The Notch4 ICD contains three nuclear localization signal (NLS) sequences (Figure 1) . Two of these are located in the RAM23 region of the ICD, the third NLS sequence is located distal to the CDC10/Ankyrin repeats. It seemed possible that the lower transcription-inducing activity of Int3sh may be related to its subcellular localization. Immunofluorescence staining (green) for V5 (Figure 6a and c) was used to localize Int3-ICD and Int3sh in transfected COS-1 cells. Int3-ICD-V5 is located in the nucleus (Figure 5a ), while Int3sh-V5 is located in the cytoplasm and nucleus (Figure 6c ). The nuclei were stained with DAPI (blue) in Figure 6b and d. Figure 6a and b display the same section; the arrow in Figure 6b points to a COS-1 cell which did not incorporate Int3-ICD-V5 vector; therefore, it is seen in Figure 6b with the DAPI, but not in Figure 6a .
Discussion
Expression of the Notch4/Int3 ICD in the mouse HC11 mammary epithelial cell line blocks the ability of these cells to make milk proteins in response to dexamethosone, insulin and prolactin (DIP) treatment (Callahan, unpublished data) , but confers on them the ability to grow in an anchorage-independent manner in soft agar (Robbins et al., 1992) . Similarly, in vivo expression of the Notch4/Int3 ICD from either the MMTV LTR or the WAP promoter blocks the development of mammary lobules and the ability of the mice to lactate. In addition, mammary tumor development occurs in 100% of these females.
We have identified a truncated version of Notch4/Int3 ICD (designated h-Int3sh) that is expressed in normal human testis and certain human tumor cell lines. The translated product of the 1.8 kb h-Int3sh RNA species begins at a methionine in the first CDC10/Ankryn repeat of the ICD and terminates at the normal translation stop site. It thus represents a naturally occurring deleted RAM23-Notch4/Int3 ICD variant that is comprised of the CDC10/Ankryn repeats and PEST regions. In the present study, we have shown that mammary gland development occurs normally in three founder lines of WAP-Int3sh transgenic mice and that the females can lactate. In another study, Uyttendaele et al. (1998) have shown that the minimal region of the Notch4 ICD required to inhibit mammary branching morphogenesis includes the RAM23 and the CDC10/ Ankryn repeats. Taken together, these results suggest that the ability of Notch4 ICD to block mammary gland development and differentiation is a consequence of CBF1-dependent Notch signaling.
Expression of h-Int3sh in the MCF10A human and HC11 'normal mouse' mammary epithelial cells confers on them the capability of anchorage-independent growth (Imatani and Callahan, 2000; Callahan, unpublished data, respectively) . In the present study, multiparous females from each of the WAP-Int3sh founder lines developed mammary tumors, with an increased latency (3.5-23 months) and decreased frequency (10-35%) compared to WAP-Int3 mice. The length of the mammary tumor latency in WAP-Int3sh mice raises a potential issue of the frequency of spontaneous mammary tumors arising in 1-2-year-old multiparous FVB/ N wild-type mice. Nieto et al. (2003) found six mammary carcinomas in five mice out of 500 FVB/N wild-type controls in a database from various laboratories. Wakefield et al. (2003) found four mice with spontaneous mammary tumors in a cohort of six multiparous female FVB/NCr mice aged 18-22 months. On the contrary, several studies (Mahler et al., 1996; Landesman-Bollag et al., 2001; White et al., 2001; Pirkmaier et al., 2003) have reported no mammary tumor incidence in various sublines of FVB/N mice in the age range of 1-2 years. In fact, it has been reported that the incidence of spontaneous mammary tumors in FVB/N mice is o1% (RD Cardiff, unpublished observation in Landesman-Bollag et al., 2001) . In a previous study of 22 wild-type FVB/N mice in our colony that were 11 months of age, none had developed spontaneous mammary tumors (Smith et al., 1995) . Thus, based on the overall low incidence of spontaneous mammary tumors in our colony and in the various sublines of FVB/N mice reported in the literature, the ability of Int3sh expression to confer on mammary epithelial cells, the capability of anchorage-independent growth and the development of mammary tumors in all three of the founder lines, we believe that the observed tumor incidence is a consequence of h-Int3sh transgene expression. This raises the question of whether Int3-induced mammary tumorigenesis is a consequence of CBF1-dependent or -independent Notch signaling. V5 (a, b) or WAP-h-Int3sh-V5 (c, d), and analysed for localization of Int3-V5 forms by indirect immunofluorescence. Int3-ICD-V5 expression was detected in the nuclei (a), while Int3-sh-V5 was predominantly found in the nucleus and cytoplasm (c). To illustrate the specificity of V5 antibody, nuclei in the same sections were stained with blue color by using 4,6-diamidino-2-phenylindole. Nucleus (e) is not transfected with WAP-Int3-ICD, therefore it shows only in (b) but not in (a) (original magnification: Â 100) Notch4 signaling in mammary development and tumorigenesis A Raafat et al Jeffries et al., 2002 have provided evidence that deletion of the RAM23 domain does not necessarily disrupt CBF1-dependent Notch signaling. They showed that a complex of dRAM23 Notch1 ICD, MastermindLike-1 (Maml) and CBF1 can form, and that this complex can stimulate CBF1/Notch-dependent transcription. They suggest that Maml acts as a tether between CBF1 and dRAM23. Further, they speculate that cell lines expressing Maml can support CBF1-dependent transcriptional activation with dRAM23 Notch ICD proteins, whereas cell lines that express low levels of Maml cannot. In fact, consistent with this proposal, we have shown in a transfection assay that hInt3sh can still activate the expression HES1 -Luciferase, albeit at a reduced efficiency. In this regard, it will be of interest to determine if MCF10A cells express high levels of Maml, and whether transformation of these cells by h-Int3sh is dependent on Maml expression.
The loss of efficiency with which h-Int3sh activates the HES1 promoter appears to be related to the decreased efficiency with which it enters the nucleus. In Drosophila, the severity of the Notch phenotype is influenced by the level of 'activated' Notch protein in the nucleus (Artavanis-Tsakonas et al., 1999). The most severe phenotypes are associated with higher levels of nuclear Notch ICD. Although we cannot formally exclude the possibility that Int3-induced tumorigenesis is through a CBF1-independent component of Notch signaling, our results are compatible with the concept of a gradient in the consequences of activated Notch4 signaling on mammary gland development and tumorigenesis. In this model, induction of mammary tumors by activated Notch4 would be at the low end of the signaling gradient. Consistent with this model is the fact that 100% of virgin WAP-Int3 females develop mammary tumors. In these mice, the transgene is active in mammary epithelium for only a short period of time during estrous (Gallahan et al., 1996) .
Materials and methods

Generation and maintenance of transgenic mice
WAP-h-Int3sh transgenic mice were generated using a 1.2 kb cDNA fragment (4855-6102 bp of Notch4 cDNA) containing the 3 0 portion of the human Notch4/Int3 gene under the control of the WAP transcription promoter. The DNA fragment was prepared for microinjection into mouse embryos using sucrose gradient centrifugation, as described previously (Gallahan et al., 1996) . Single-cell mouse embryos were harvested from the inbred FVB/N strain of mice (Charles River Labs) and the purified 1.2-kbp h-Int3-sh fragment was microinjected into the pronuclei of these embryos. Microinjected embryos were transferred to the oviducts of pseudopregnant FVB/N females. To identify the resulting transgenic progeny, genomic DNA was isolated from tail biopsies, digested with EcoRI and BamHI and evaluated by Southern blot analysis for the transgene. Subsequent generations of the founder lines were backcrossed with FVB/N mice from our colony. These mice have been genetically separated from other sources of FVB/N mice for the past 10 years.
RNA preparation and analysis
Founders bearing the WAP-h-Int3sh transgene were tested for transgene expression in mammary gland RNA from 15-dayspregnant transgenic mice. RNA was prepared using Trizol according to the manufacturer's manual (Invitrogen Life Technologies). To detect expression of WAP-h-Int3sh in mice, RT-PCR analysis was performed using WAP forward and hInt3sh reverse primer.
Preparation of tissue for analysis of mammary gland morphology
Mice were euthanized and mammary glands were examined grossly under a dissecting microscope. Mammary whole mounts were prepared from the fourth abdominal gland on the right side. The glands were removed, stretched flat on a microscope slide and fixed on Carnoy's fixative for 1 h at room temperature, then rehydrated in 70% ethanol (15 min), rinsed in water (5 min), and stained in carmine alum (2 g/l) overnight (14-18 h) at 41C. The stained gland was progressively dehydrated in ethanol (70-100%) in three steps (15 min/step) and cleared in toluene (15 min) and mounted under coverslips in permount.
Preparation of tissue for histology
Mammary glands were routinely fixed in 4% fresh prepared paraformaldehyde in PBS (pH 7.4) for 2 h, rinsed through several changes of buffer, dehydrated in ethanol, and embedded in paraffin. Paraffin sections (5 mm) were placed on slides, de-paraffanized and stained with H&E.
Tissue culture and transfection of Cos-1 cells
Cos-1 cells cultured on slides were grown in DMEM supplemented with penicillin-streptomycin and 10% FCS under 5% CO 2 -95% air at 371C. At 24 h before transfection, cells were seeded on six-well plates for Luciferase assay and on chamber slides for immunohistochemistry. DNA for transfection was prepared using the Plasmid Maxi Kit (Qiagen, Hilden, Germany). Transfection was performed according to the manufacturer's protocol, using the FUGENE 6 Transfection Kit (Roche Diagnostics, Mannheim, Germany).
Immunohistochemistry
A region encoding the full-length mouse Notch4/Int3 (nucleotides 98-6008 bp of the cDNA GenBank Accession #M80456) was cloned into the EcoRI and XbaI sites of pEF1-V5/His expression vectors (Invtrogen) and was designated as pEF1-WT. The expression vector containing the region corresponding to the ICD of the mouse Notch4/Int3 protein (nucleotides 4283-6008 bp of the cDNA) was generated by the removal of the region between the KpnI and Kpn21 sites from pEF1-WT, and was designated as pEF-ICD. The short form of human Notch4/Int3 corresponding to the 1.8 kb Notch4/Int3 RNA species, which lacks the CBF1-binding domain of Notch4/ Int3-ICD (nucleotide 4855-6099 bp of the cDNA GenBank accession #U95299), was amplified by PCR using the primer sets, the forward 5 0 -GTCGAATTCACACCCCTGATGTC AGCAGTTTGCTG-3 0 (EcoRI þ Kozak box þ 4855-4580) and the reverse 5 0 -GTCTAGACGTTTTTTA CCCTCTCCT CCTTGGTTTATGG GCA-3 0 (XbaI þ 6099-6068), and was cloned into the EcoRI and XbaI sites of the pEF1-V5/His expression vector, and was designated as pEF-Int3sh.
After a brief washing in PBS, transfected COS-1 cells on chamber slides were fixed for 5 min in acetone, followed by Notch4 signaling in mammary development and tumorigenesis A Raafat et al brief washing in PBS (pH 7.4). After 30 min blocking in PBS-1% bovine serum albumin, cells were incubated for 1 h with anti-V5 antibody (Invitrogen Life Technologies cat# R960) diluted 200 Â in PBS-1% bovine serum albumin. After being washed twice with PBS and stained with fluorochrome-coupled anti-mouse secondary antibodies, samples were mounted for microscopic inspection in mounting medium (DAPI, Vector Lab. Inc.). The subcellular localization of h-Int3sh and Int3-ICD was determined in at least 100 cells in each experimental condition. Staining was considered as nuclear when it was exclusively nuclear; in all other cases, it was considered cytoplasmic.
Luciferase reporter assay
A luciferase reporter plasmid containing HES-1 promoter region was used to analyse the ability of Notch ICD and hInt3sh to induce the HES-1 promoter within cells. Cos-1 cells were cotransfected with I mg HES-1-Luc, 20 ng of RL-TK (renilla luciferase control plasmid; Promega), and 0.1, 0.3 or 0.5 mg of the indicated plasmid. At 36 h after transfection, cells were lysed in 1 Â PLB buffer and luciferase, and renilla light units were measured in LUMAT LB 9507 (Berthold Bio., Germany) luminometer according to the manufacturer's protocol for the Dual Luciferase assay (Promega). Luciferase values were corrected for transfection efficiency by dividing luciferase light units by renilla light units (expressed as relative luciferase units). For all experiments, three cell samples were transfected and processed independently. Experiments were repeated at least three times.
